ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,062.00
-0.10%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36161
0.00%
Bitcoin
66,182.25
-1.13%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Nighthawk Biosciences Inc (NHWK)

  7. Nighthawk Biosciences Inc (NHWK) News

NHWK

Nighthawk Biosciences (NHWK)

Nighthawk Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:NHWK
DateTimeSourceHeadlineSymbolCompany
05/03/20243:00PMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:NHWKNighthawk Biosciences Inc
05/03/20246:18AMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:NHWKNighthawk Biosciences Inc
05/02/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
04/30/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
04/29/20247:10AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
04/22/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
04/01/20243:52PMEdgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405AMEX:NHWKNighthawk Biosciences Inc
03/19/20247:30AMGlobeNewswire Inc.Scorpius Holdings Awarded Contract in Excess of $1 Million with NIH-Funded Researcher at a Major UniversityAMEX:NHWKNighthawk Biosciences Inc
03/14/20247:30AMGlobeNewswire Inc.Scorpius Holdings Accepted as a Member of the US Government’s BioMaP-ConsortiumAMEX:NHWKNighthawk Biosciences Inc
03/13/20245:17AMEdgar (US Regulatory)Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]AMEX:NHWKNighthawk Biosciences Inc
03/13/20245:01AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
03/12/20244:00PMGlobeNewswire Inc.Scorpius Holdings, Inc. Announces Closing of Public OfferingAMEX:NHWKNighthawk Biosciences Inc
03/07/202411:20PMGlobeNewswire Inc.Scorpius Holdings, Inc. Announces Pricing of Public OfferingAMEX:NHWKNighthawk Biosciences Inc
03/07/20243:18PMGlobeNewswire Inc.Scorpius Holdings, Inc. Announces Proposed Public Offering of Common StockAMEX:NHWKNighthawk Biosciences Inc
03/07/20247:30AMGlobeNewswire Inc.Scorpius Holdings Estimates Greater than 375% Sequential Increase in Revenue for the Fourth Quarter of 2023 Compared to the Third Quarter of 2023AMEX:NHWKNighthawk Biosciences Inc
02/06/20248:34AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
02/06/20247:00AMGlobeNewswire Inc.NightHawk Biosciences Completes Name Change to Scorpius Holdings; Trading to Commence Under “SCPX” Effective at the Market Open TodayAMEX:NHWKNighthawk Biosciences Inc
02/01/20247:00AMGlobeNewswire Inc.NightHawk’s Scorpius BioManufacturing Subsidiary Announces the Promotion of Joe Payne to President and Chief Operating OfficerAMEX:NHWKNighthawk Biosciences Inc
01/30/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
01/30/20247:00AMGlobeNewswire Inc.NightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing NoteAMEX:NHWKNighthawk Biosciences Inc
01/26/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
01/25/20247:30AMGlobeNewswire Inc.NightHawk’s Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical ProgramAMEX:NHWKNighthawk Biosciences Inc
01/22/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
01/16/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
01/16/20247:30AMGlobeNewswire Inc.NightHawk’s Scorpius BioManufacturing Subsidiary Commences Work on Preclinical Program for New ClientAMEX:NHWKNighthawk Biosciences Inc
01/11/20243:59PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
01/08/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
01/08/20247:30AMGlobeNewswire Inc.NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Transition to a Large Molecule Biomanufacturing CDMOAMEX:NHWKNighthawk Biosciences Inc
01/03/20247:30AMGlobeNewswire Inc.NightHawk Biosciences Commences Work on Multi-Million-Dollar Development and Manufacturing Agreement For a Leading National UniversityAMEX:NHWKNighthawk Biosciences Inc
12/27/20233:57PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
 Showing the most relevant articles for your search:AMEX:NHWK

Your Recent History

BOV
PETRG269
PETRG269 Ex:24,12
LSE
0YXG
Broadcom
NYSE
NMD
EU
T714S
T714S
BITMOT
762830
C Veneto Ser Tf 4,2% Lg3...
BIT
F16282
Vontobel Financial Produ...
TSXV
MPI
UNSW
PRAIETH
Proto Rai Reflex Index
LSE
IMBS
Ish Us Mbs
POLO
CHADUSDT
Chad Coin
NYSE
SMWB
Similarweb
TG
A2RYPC
Volksbank Wien
EU
U247S
U247S
COIN
EDGGBP
Edgeware
NYSE
IRS
IRSA Inversiones and Rep...
NASDAQI
NQCAPSTT
Capital Strength Total R...
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved